The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sequential pembrolizumab (pembro) and chemotherapy (chemo) in newly diagnosed, early unfavorable, or advanced-stage classical Hodgkin lymphoma (cHL): The phase 2 KEYNOTE-C11 study.
 
Jane N. Winter
Honoraria - Merck
Consulting or Advisory Role - Agios (I); Ariad (I); Bristol-Myers Squibb (I); CVS Caremark (I); Epizyme (I); Gilead Sciences (I); Janssen (I); Merck; Novartis (I); Novartis (I); Takeda (I)
Research Funding - Astellas Pharma (I); Astellas Pharma (Inst); Celgene (I); Cellectis (I); Daiichi Sankyo (I); Forty Seven (I); Merck; Novartis (I)
Patents, Royalties, Other Intellectual Property - Royalties from UptoDate, Inc. (I)
 
Akash Nahar
Employment - Merck
 
Eunhee Kim
Employment - Merck
 
Patricia Marinello
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme